MENU
LGND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ligand Pharmaceuticals (LGND) Ownership - Who owns Ligand Pharmaceuticals?
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.02B
P/E Ratio
46.19
Total Cash
256.17M
Projected Growth
N/A
Total Debt
7.11M
Revenue
167.13M
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash/Share
13.30
Total Debt/Equity
8.88
Revenue/Share
9.14 USD as % of share price
Fundamentals
LGND
Capitalization
2.02B
P/E Ratio
46.19
Risk (Beta)
1.10
Dividend Yield
N/A
Total Cash
256M
Total Cash/Share
13.30
Total Debt
7.11M
Total Debt/Equity
8.88
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.14%
Revenue
167M
ROE
N/A
Book Value
830M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
20K
Current Ratio
8.93
Current Revenue Per Employee
629588.25
Dividends Per Share - Security
N/A
EBITDA
40.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.37
Revenue To Assets
-0.47
Shares Held By Institutions
4.5B
Shares Outstanding - Current
19.3M
Total Liabilities
111M
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.184
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com